High-throughput sequencing reveals principles of adeno-associated virus serotype 2 integration

Journal of Virology

Volumn 87, Issue 15, 2013, Pages 8559-8568

  Janovitz, Tyler ^a,b   Klein, Isaac A ^a,c   Oliveira, Thiago ^c   Mukherjee, Piali ^a   Nussenzweig, Michel C ^c   Sadelain, Michel ^a   Falck Pedersen, Erik ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELICASE;

ADENO ASSOCIATED VIRUS; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA BINDING MOTIF; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENE INSERTION; GENE LOCUS; GENOME ANALYSIS; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS REPLICATION;

EID: 84880584473     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01135-13     Document Type: Article

References (65)

1. Holmes EC. 2011. The evolution of endogenous viral elements. Cell Host Microbe 10:368-377.
2. Kotin RM, Siniscalco M, Samulski RJ, Zhu XD, Hunter L, Laughlin CA, McLaughlin S, Muzyczka N, Rocchi M, Berns KI. 1990. Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. U. S. A. 87:2211-2215.
3. Daya S, Berns KI. 2008. Gene therapy using adeno-associated virus vectors. Clin. Microbiol. Rev. 21:583-593.
4. Flotte TR. 2007. Gene therapy: the first two decades and the current state-of-the-art. J. Cell. Physiol. 213:301-305.
5. Ward P, Walsh CE. 2012. Targeted integration of a rAAV vector into the AAVS1 region. Virology 433:356-366.
6. Recchia A, Perani L, Sartori D, Olgiati C, Mavilio F. 2004. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors. Mol. Ther. 10:660-670.
7. Cortés ML, Oehmig A, Saydam O, Sanford JD, Perry KF, Fraefel C, Breakefield XO. 2008. Targeted integration of functional human ATM cDNA into genome mediated by HSV/AAV hybrid amplicon vector. Mol. Ther. 16:81-88.
8. Urcelay E, Ward P, Wiener SM, Safer B, Kotin RM. 1995. Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep. protein. J. Virol. 69:2038-2046.
9. Surosky RT, Urabe M, Godwin SG, McQuiston SA, Kurtzman GJ, Ozawa K, Natsoulis G. 1997. Adeno associated virus Rep. proteins target DNAsequences to a unique locus in the human genome. J. Virol. 71:7951-7959.
10. Urabe M, Kogure K, Kume A, Sato Y, Tobita K, Ozawa K. 2003. Positive and negative effects of adeno associated virus Rep. on AAVS1-targeted integration. J. Gen. Virol. 84:2127-2132.
11. Young SM, Samulski RJ. 2001. Adeno-associated virus (AAV) sitespecific recombination does not require a Rep-dependent origin of replication within the AAV terminal repeat. Proc. Natl. Acad. Sci. U. S. A. 98:13525.
12. Pieroni L, Fipaldini C, Monciotti A, Cimini D, Sgura A, Fattori E, Epifano O, Cortese R, Palombo F, La Monica N. 1998. Targeted integration of adeno-associated virus-derived plasmids in transfected human cells. Virology 249:249-259.
13. Philpott NJ, Giraud-Wali C, Dupuis C, Gomos J, Hamilton H, Berns KI, Falck-Pedersen E. 2002. Efficient integration of recombinant adenoassociated virus DNA vectors requires a p5-rep sequence in cis. J. Virol. 76:5411-5421.
14. Samulski RJ, Zhu X, Xiao X, Brook JD, Housman DE, Epstein N, Hunter LA. 1991. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10:3941-3950.
15. Kotin RM, Linden RM, Berns KI. 1992. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 11:5071-5078.
16. Giraud C, Winocour E, Berns KI. 1994. Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence. Proc. Natl. Acad. Sci. U. S. A. 91:10039-10043.
17. Linden RM, Ward P, Giraud C, Winocour E, Berns KI. 1996. Sitespecific integration by adeno associated virus. Proc. Natl. Acad. Sci. U. S. A. 93:11288-11294.
18. Linden RM, Winocour E, Berns KI. 1996. The recombination signals for adeno-associated virus site-specific integration. Proc. Natl. Acad. Sci. U. S. A. 93:7966-7972.
19. Meneses P, Berns KI, Winocour E. 2000. DNA sequence motifs which direct adeno-associated virus site-specific integration in a model system. J. Virol. 74:6213-6216.
20. Im DS, Muzyczka N. 1990. The AAV origin binding protein Rep68 is an ATP-dependent site specific endonuclease with DNA helicase activity. Cell 61:447-457.
21. James JA, Escalante CR, Yoon-Robarts M, Edwards TA, Linden RM, Aggarwal AK. 2003. Crystal structure of the SF3 helicase from adenoassociated virus type 2. Structure 11:1025-1035.
22. Snyder RO, Im DS, Ni T, Xiao X, Samulski RJ, Muzyczka N. 1993. Features of the adeno associated virus origin involved in substrate recognition by the viral Rep. protein. J. Virol. 67:6096-6104.
23. Li Z. 2003. Characterization of the adenoassociated virus Rep. protein complex formed on the viral origin of DNA replication. Virology 313:364-376.
24. Maggin JE, James JA, Chappie JS, Dyda F, Hickman AB. 2012. The amino acid linker between the endonuclease and helicase domains of adeno-associated virus type 5 Rep plays a critical role in DN-dependent oligomerization. J. Virol. 86:3337-3346.
25. Zarate-Perez F, Mansilla-Soto J, Bardelli M, Burgner JW, Villamil-Jarauta M, Kekilli D, SamsoM, Linden RM, Escalante CR. 2013. The oligomeric properties of the adeno-associated virus Rep68 reflect its multifunctionality. J. Virol. 87:1232-1241.
26. Mansilla-Soto J, Yoon-Robarts M, Rice WJ, Arya S, Escalante CR, Linden RM. 2009. DNA structure modulates the oligomerization properties of the AAV initiator protein Rep68. PLoS Pathog. 5:e1000513. doi: 10.1371/journal.ppat.1000513..
27. Weitzman MD, Kyöstiö SR, Kotin RM, Owens RA. 1994. Adenoassociated virus (AAV) Rep. proteins mediate complex formation between AAVDNAand its integration site in human DNA. Proc. Natl. Acad. Sci. U. S. A. 91:5808-5812.
28. Drew HR, Lockett LJ, Both GW. 2007. Increased complexity of wild-type adeno-associated virus-chromosomal junctions as determined by analysis of unselected cellular genomes. J. Gen. Virol. 88:1722-1732.
29. Hüser D, Gogol-Döring A, Lutter T, Weger S, Winter K, Hammer Cathomen E-MT, Reinert K, Heilbronn R. 2010. Integration preferences of wildtype AAV-2 for consensus rep-binding sites at numerous loci in the human genome. PLoS Pathog. 6:e1000985. doi:10.1371/journal.ppat.1000985.
30. Klein IA, Resch W, Jankovic M, Oliveira T, Yamane A, Nakahashi H, Di Virgilio M, Bothmer A, Nussenzweig A, Robbiani DF, Casellas R, Nussenzweig MC. 2011. Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes. Cell 147:95-106.
31. Oliveira TY, Resch W, Jankovic M, Casellas R, Nussenzweig MC, Klein IA. 2012. Translocation capture sequencing: A method for high throughput mapping of chromosomal rearrangements. J. Immunol. Methods 375:176-181.
32. Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, Jones SJ, Marra MA. 2009. Circos: an information aesthetic for comparative genomics. Genome Res. 19:1639-1645.
33. Quinlan AR, Hall IM. 2010. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26:841-842.
34. Maere S, Heymans K, Kuiper M. 2005. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21:3448-3449.
35. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. 2011. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27:431-432.
36. Bantel-Schaal UU, Hausen zur, HH. 1984. Characterization of the DNA of a defective human parvovirus isolated from a genital site. Virology 134:52-63.
37. Walz CMC, Anisi TRT, Schlehofer JRJ, Gissmann LL, Schneider AA, Müller MM. 1998. Detection of infectious adeno-associated virus particles in human cervical biopsies. Virology 247:97-105.
38. Philpott NJ, Gomos J, Berns KI, Falck-Pedersen E. 2002. A p5 integration efficiency element mediates Rep-dependent integration into AAVS1 at chromosome 19. Proc. Natl. Acad. Sci. U. S. A. 99:12381-12385.
39. Hamilton H, Gomos J, Berns KI, Falck-Pedersen E. 2004. Adenoassociated virus site-specific integration and AAVS1 disruption. J. Virol. 78:7874-7882.
40. Yang CC, Xiao X, Zhu X, Ansardi DC, Epstein ND, Frey MR, Matera AG, Samulski RJ. 1997. Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno associated virus integration in vivo and in vitro. J. Virol. 71:9231-9247.
41. Wu JJ, Davis MDM, Owens RAR. 1999. Factors affecting the terminal resolution site endonuclease, helicase, and ATPase activities of adenoassociated virus type 2 Rep. proteins. J. Virol. 73:8235-8244.
42. Brister JR, Muzyczka N. 1999. Rep-mediated nicking of the adenoassociated virus origin requires two biochemical activities, DNA helicase activity and transesterification. J. Virol. 73:9325-9336.
43. Lamartina S, Ciliberto G, Toniatti C. 2000. Selective cleavage of AAVS1 substrates by the adeno associated virus type 2 rep68 protein is dependent on topological and sequence constraints. J. Virol. 74:8831-8842.
44. Hewitt FC, Samulski RJ. 2010. Creating a novel origin of replication through modulating DNA protein interfaces. PLoS One 5:e8850. doi:10.1371/journal.pone.0008850.
45. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A,Sougnez C, Stange-Thomann N, Stojanovic N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, Gregory S, Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, Richardson P, Wenning S, Slezak T, Doggett N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921.
46. Venter JC. 2001. The sequence of the human genome. Science 291:1304-1351.
47. Saxonov S, Berg P, Brutlag DL. 2006. A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc. Natl. Acad. Sci. U. S. A. 103:1412-1417.
48. Crawford GE. 2005. Genome-wide mapping of DNase hypersensitive sites using massively parallel signature sequencing (MPSS). Genome Res. 16:123-131.
49. Koch CM, Andrews RM, Flicek P, Dillon SC, Karaoz U, Clelland GK, Wilcox S, Beare DM, Fowler JC, Couttet P, James KD, Lefebvre GC, Bruce AW, Dovey OM, Ellis PD, Dhami P, Langford CF, Weng Z, Birney E, Carter NP, Vetrie D, Dunham I. 2007. The landscape of histone modifications across 1% of the human genome in five human cell lines. Genome Res. 17:691-707.
50. Li J. 2002. Association of the histone methyltransferase Set2 with RNA polymerase II plays a role in transcription elongation. J. Biol. Chem. 277:49383-49388.
51. Pauler FM, Sloane MA, Huang R, Regha K, Koerner MV, Tamir I, Sommer A, Aszodi A, Jenuwein T, Barlow DP. 2008. H3K27me3 forms BLOCs over silent genes and intergenic regions and specifies a histone banding pattern on a mouse autosomal chromosome. Genome Res. 19:221-233.
52. Young MD, Willson TA, Wakefield MJ, Trounson E, Hilton DJ, Blewitt ME, Oshlack A, Majewski IJ. 2011. ChIP-seq analysis reveals distinct H3K27me3 profiles that correlate with transcriptional activity. Nucleic Acids Res. 39:7415-7427.
53. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR. 2004. A census of human cancer genes. Nat. Rev. Cancer. 4:177-183.
54. Wang P-R, Xu M, Toffanin S, Li Y, Llovet JM, Russell DW. 2012. Induction of hepatocellular carcinoma by in vivo gene targeting. Proc. Natl. Acad. Sci. U. S. A. 109:11264-11269.
55. Donsante A, Miller DG, Li Y, Vogler C, Brunt EM, Russell DW, Sands MS. 2007. AAV vector integration sites in mouse hepatocellular carcinoma. Science 317:477.
56. Hickman AB, Ronning DR, Perez ZN, Kotin RM, Dyda F. 2004. The nuclease domain of adeno-associated virus rep coordinates replication initiation using two distinct DNA recognition interfaces. Mol. Cell 13:403-414.
57. Zhou X, Zolotukhin I, Im DS, Muzyczka N. 1999. Biochemical characterization of adeno-associated virus rep68 DNA helicase and ATPase activities. J. Virol. 73:1580-1590.
58. Guirouilh-Barbat J, Redon C, Pommier Y. 2008. Transcription-coupled DNAdouble-strand breaks are mediated via the nucleotide excision repair and the Mre11-Rad50-Nbs1 complex. Mol. Biol. Cell 19:3969-3981.
59. Miller DG, Petek LM, Russell DW. 2004. Adeno-associated virus vectors integrate at chromosome breakage sites. Nat. Genet. 36:767-773.
60. Miller DG, Trobridge GD, Petek LM, Jacobs MA, Kaul R, Russell DW. 2005. Large-scale analysis of adeno-associated virus vector integration sites in normal human cells. J. Virol. 79:11434-11442.
61. François A, Guilbaud M, Awedikian R, Chadeuf G, Moullier P, Salvetti A. 2005. The cellular TATA binding protein is required for rep-dependent replication of a minimal adeno-associated virus type 2 p5 element. J. Virol. 79:11082-11094.
62. Murphy MM, Gomos-Klein JJ, Stankic MM, Falck-Pedersen EE. 2007. Adeno-associated virus type 2 p5 promoter: a rep-regulated DNA switch element functioning in transcription, replication, and site specific integration. J. Virol. 81:3721-3730.
63. Davis MD, Wu J, Owens RA. 2000. Mutational analysis of adenoassociated virus type 2 Rep68 protein endonuclease activity on partially single-stranded substrates. J. Virol. 74:2936-2942.
64. Walker SL, Wonderling RS, Owens RA. 1997. Mutational analysis of the adeno-associated virus type 2 Rep68 protein helicase motifs. J. Virol. 71:6996-7004.
65. Project Consortium ENCODE. 2011. A user's guide to the encyclopedia of DNAelements (ENCODE). PLoS Biol. 9:e1001046. doi:10.1371/journal.pbio.1001046.